Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-417969

Director acquired 21,829 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Postma Robert W Director 2026-10-06 Grant or award +21,829 $0.74 $16,250 80,438 D: show line 1 in the form
Loading xslF345X06/ownership.xml…